YP
GILD icon

YANKCOM Partnership’s Gilead Sciences GILD Stock Holding History

YANKCOM Partnership’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40.2K Hold
270
– – 0.01% 209
2026
Q2 		$34.1K Hold
270
– – 0.01% 207
2026
Q1 		$37.6K Hold
270
– – 0.02% 201
2025
Q4 		$33.1K Hold
270
– – 0.01% 210
2025
Q3 		$30K Sell
270
-24
-8% -$2.73K 0.01% 201
2025
Q2 		$32.6K Hold
294
– – 0.02% 191
2025
Q1 		$32.9K Sell
294
-7
-2% -$722 0.02% 188
2024
Q4 		$27.8K Buy
+301
New +$27.1K 0.01% 195

Other funds holding GILD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

YANKCOM Partnership's GILD Position: Q3 2026 in Review

YANKCOM Partnership held its Gilead Sciences (GILD) position steady in Q3 2026 at 270 shares worth $40.2K. The position accounts for 0.01% of the portfolio, ranked #209.

YANKCOM Partnership first reported a position in GILD in Q4 2024 and has held it in 8 quarters since. 1,582 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • YANKCOM Partnership held 270 shares of Gilead Sciences worth $40.2K as of Q3 2026.
  • YANKCOM Partnership left its Gilead Sciences share count unchanged in Q3 2026.
  • Gilead Sciences made up 0.01% of YANKCOM Partnership's portfolio in Q3 2026, its #209 holding.
  • YANKCOM Partnership first reported a position in Gilead Sciences in Q4 2024 and has held it in 8 quarters since.
  • 1,582 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.